Skip to content
10-K

Annual Report

IRADIMED CORP IRMD

0001104659-26-024691

← back to feed
Filed
Mar 6, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 28, 2026 12.78M sh
Shares Diluted FY 2025 · Dec 31, 2025 12.85M sh
Dividends Paid FY 2025 · Dec 31, 2025 $15.04M
Capex FY 2025 · Dec 31, 2025 $7.77M
Operating Cash Flow FY 2025 · Dec 31, 2025 $24.95M
Cash And Equivalents FY 2025 · Dec 31, 2025 $51.16M
Stockholders Equity FY 2025 · Dec 31, 2025 $94.62M
Current Liabilities FY 2025 · Dec 31, 2025 $10.18M
Total Liabilities FY 2025 · Dec 31, 2025 $14.16M
Current Assets FY 2025 · Dec 31, 2025 $81.2M
Total Assets FY 2025 · Dec 31, 2025 $108.78M
Eps Diluted FY 2025 · Dec 31, 2025 $1.75
Eps Basic FY 2025 · Dec 31, 2025 $1.77
Sga Expense FY 2025 · Dec 31, 2025 $17.78M
Rd Expense FY 2025 · Dec 31, 2025 $2.98M
Net Income FY 2025 · Dec 31, 2025 $22.48M
Operating Income FY 2025 · Dec 31, 2025 $26.15M
Gross Profit FY 2025 · Dec 31, 2025 $64.32M
Cost Of Revenue FY 2025 · Dec 31, 2025 $19.49M
Revenue FY 2025 · Dec 31, 2025 $83.81M